Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Zoll Medical Corporation clinical trials
Part of Asahi Kasei Corporation. Source
The registry lists 67 studies whose lead sponsor is Zoll Medical Corporation or one of 4 companies grouped under it. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Keep track of what changes. Save the Zoll Medical Corporation studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Zoll Medical Corporation.
- Zoll Medical Corporation35 studiesSame company
Something wrong?
- ZOLL Circulation, Inc., USA10 studies →Acquired — became part of Zoll Medical Corporation, Oct 12, 2004 · source ↗
Something wrong?
- Respicardia, Inc.8 studies →Acquired — became part of Zoll Medical Corporation, 2021 · source ↗
Something wrong?
- Advanced Circulatory Systems7 studies →Acquired
Something wrong?
- TherOx7 studies →Acquired
Something wrong?
Focus areas
Conditions Zoll Medical Corporation leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 67. Browse all 67 →
- Janus II FeasibilityRecruitingNCT06556693Not applicable
- Remote Monitoring and Optimization of Heart Failure TherapyNot yet recruitingNCT07622472Not applicable
- Pre-hospital Ventilation Clinical StudyEnrolling by invitationNCT05604430
- SuperSaturated Oxygen Comprehensive Observational RegistryRecruitingNCT06438315
Sponsor listed in the registry: TherOx · TherOx — acquired company within the Zoll Medical Corporation group
- Prospective WCD Post CABG Registry (CABG Registry)RecruitingNCT06570902
- Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter DefibrillatorRecruitingNCT04504188Not applicable
- remedē System Therapy StudyActive, not recruitingNCT03884660
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.TerminatedNCT04743245Not applicable
Sponsor listed in the registry: TherOx · TherOx — acquired company within the Zoll Medical Corporation group
- Evaluation of the Delivery of Optimized Supersaturated Oxygen Therapy to Treat Patients With an Acute Heart AttackCompletedNCT01630707Not applicable
Sponsor listed in the registry: TherOx · TherOx — acquired company within the Zoll Medical Corporation group
- STEMI Cool Pilot Trial to Assess Cooling as an Adjunctive Therapy to PCI In Patients With Acute MI (Phase A)WithdrawnNCT03361995Not applicable
Sponsor listed in the registry: ZOLL Circulation, Inc., USA · First submitted after ZOLL Circulation, Inc., USA became part of Zoll Medical Corporation
- Janus Feasibility StudyCompletedNCT03985527Not applicable
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter DefibrillatorTerminatedNCT04292405
- AED 3 Post-Approval StudyActive, not recruitingNCT05013333Not applicable
- Heart Failure Optimization StudyCompletedNCT03016754
- Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients with Heart Failure with Reduced or Mildly Reduced Left Ventricular Ejection FractionCompletedNCT06313840
- Benefits of Microcor in Ambulatory Decompensated Heart FailureCompletedNCT04096040Not applicable
- Benefits of µCor in Ambulatory Decompensated Heart FailureCompletedNCT03476187Not applicable
- LifeVest Safety and Efficacy in Real Life Settings in FranceCompletedNCT03319160
- FiO2 Closed Loop Control VentilationCompletedNCT02810080
- Rapid Treatment of Shock Without TraumaCompletedNCT05073354
- RapidShock Post-Approval StudyCompletedNCT04014842Not applicable
- A Prospective Real-World Multi-Center Post-Market Observational Evaluation of Supersaturated O2 Therapy Using the TherOx® Downstream® SystemTerminatedNCT05156996
Sponsor listed in the registry: TherOx · TherOx — acquired company within the Zoll Medical Corporation group
- REperfusion With Cooling in CerebraL Acute IscheMia IICompletedNCT03804060Not applicable
Sponsor listed in the registry: ZOLL Circulation, Inc., USA · First submitted after ZOLL Circulation, Inc., USA became part of Zoll Medical Corporation
- Verification of Prediction AlgorithmCompletedNCT02863666
- Incorporating Supersaturated Oxygen in ShockWithdrawnNCT04876040Not applicable
Sponsor listed in the registry: TherOx · TherOx — acquired company within the Zoll Medical Corporation group
- Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT)CompletedNCT02603835Not applicable
Sponsor listed in the registry: TherOx · TherOx — acquired company within the Zoll Medical Corporation group
- Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac RehabilitationWithdrawnNCT05957172
- Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications ChangesCompletedNCT05505136
- Ambulatory Post-Syncope Arrhythmia Protection Feasibility StudyCompletedNCT02188147Not applicable
- Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientsCompletedNCT04754204
- CirQPOD Shoulder StudyWithdrawnNCT04299776Not applicable
- Feasibility Study of the µCor Heart Failure and Arrhythmia Management System (PATCH)CompletedNCT04512703
- Heart Sounds RegistryCompletedNCT03203629
- Post Approval Study of the remedē SystemCompletedNCT03425188
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- COOL AMI EU Pivotal Trial to Assess Cooling as an Adjunctive Therapy to PCI In Patients With Acute MI (Phase A)CompletedNCT03173313Not applicable
Sponsor listed in the registry: ZOLL Circulation, Inc., USA · First submitted after ZOLL Circulation, Inc., USA became part of Zoll Medical Corporation
- Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) StudyTerminatedNCT02481206Not applicable
- Heart Sounds Measurement Using the Wearable Cardioverter Defibrillator (HS-WCD) StudyCompletedNCT02825966Not applicable
- COOL-AMI EU Case Series Clinical StudyCompletedNCT02070913
Sponsor listed in the registry: ZOLL Circulation, Inc., USA · First submitted after ZOLL Circulation, Inc., USA became part of Zoll Medical Corporation
- COOL AMI EU Pilot Trial to Assess Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial InfarctionCompletedNCT02509832Not applicable
Sponsor listed in the registry: ZOLL Circulation, Inc., USA · First submitted after ZOLL Circulation, Inc., USA became part of Zoll Medical Corporation
- Measuring Thoracic Impedance in Hemodialysis Patients With the u-Cor Monitoring SystemCompletedNCT03072732Not applicable
- LifeVest Trends Validation ProtocolCompletedNCT02149290
- Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to ContinenceCompletedNCT01920035Not applicable
Sponsor listed in the registry: ZOLL Circulation, Inc., USA · First submitted after ZOLL Circulation, Inc., USA became part of Zoll Medical Corporation
- Rapid Intravascular Cooling in Myocardial Infarction as Adjunctive to Percutaneous Coronary InterventionCompletedNCT00417638Not applicable
Sponsor listed in the registry: ZOLL Circulation, Inc., USA · First submitted after ZOLL Circulation, Inc., USA became part of Zoll Medical Corporation
- Cardiovascular Diagnosis Using µ-Cor - an Interventional Pilot TrialWithdrawnNCT02700191Not applicable
- Vital Signs Validation Study of the μ-Cor System (ViVUS Validation)CompletedNCT02975050
- Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour)TerminatedNCT02388880Not applicable
Sponsor listed in the registry: Advanced Circulatory Systems · Advanced Circulatory Systems — acquired company within the Zoll Medical Corporation group
- LifeVest Wearable Cardioverter Defibrillator WEARIT-III RegistryCompletedNCT02700880
- Circulation Improving Resuscitation Care (CIRC)CompletedNCT00597207Not applicable
- Respicardia, Inc. Pivotal Trial of the remedē SystemCompletedNCT01816776Not applicable
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Therapeutic Hypothermia With IntraVascular Temperature Management (IVTM) in Post-Cardiogenic Cardiac Arrest and Post-Return of Spontaneous Circulation Patients in JapanCompletedNCT01847482Not applicable
Sponsor listed in the registry: ZOLL Circulation, Inc., USA · First submitted after ZOLL Circulation, Inc., USA became part of Zoll Medical Corporation